Matthew S McCoy
Matthew S McCoy
Verified email at
Cited by
Cited by
An ethical framework for global vaccine allocation
EJ Emanuel, G Persad, A Kern, A Buchanan, C Fabre, D Halliday, J Heath, ...
Science 369 (6509), 1309-1312, 2020
Conflicts of interest for patient-advocacy organizations
MS McCoy, M Carniol, K Chockley, JW Urwin, EJ Emanuel, H Schmidt
New England Journal of Medicine 376 (9), 880-885, 2017
Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access
LM Herzog, OF Norheim, EJ Emanuel, MS McCoy
bmj 372, 2021
Why there are no “potential” conflicts of interest
MS McCoy, EJ Emanuel
JAMA 317 (17), 1721-1722, 2017
Ethical advocacy across the autism spectrum: Beyond partial representation
MS McCoy, EY Liu, ASF Lutz, D Sisti
The American Journal of Bioethics 20 (4), 13-24, 2020
National Standards for Public Involvement in Research: missing the forest for the trees
MS McCoy, KR Jongsma, P Friesen, M Dunn, CP Neuhaus, L Rand, ...
Journal of Medical Ethics 44 (12), 801-804, 2018
Patient and public involvement: Two sides of the same coin or different coins altogether?
MS McCoy, J Warsh, L Rand, M Parker, M Sheehan
Bioethics 33 (6), 708-715, 2019
Patient‐engaged research: Choosing the “right” patients to avoid pitfalls
EA Largent, HF Lynch, MS McCoy
Hastings Center Report 48 (5), 26-34, 2018
Conflicts of interest of public speakers at meetings of the Anesthetic and Analgesic Drug Products Advisory Committee
MS McCoy, O Pagán, G Donohoe, GP Kanter, RS Litman
JAMA Internal Medicine 178 (7), 996-997, 2018
Industry support of patient advocacy organizations: the case for an extension of the sunshine act provisions of the affordable care act
MS McCoy
American journal of public health 108 (8), 1026-1030, 2018
What are the obligations of pharmaceutical companies in a global health emergency?
EJ Emanuel, A Buchanan, SY Chan, C Fabre, D Halliday, J Heath, ...
The Lancet 398 (10304), 1015-1020, 2021
Sharing patient data without exploiting patients
MS McCoy, S Joffe, EJ Emanuel
Jama 323 (6), 505-506, 2020
Public involvement in the governance of population-level biomedical research: Unresolved questions and future directions
S Erikainen, P Friesen, L Rand, K Jongsma, M Dunn, A Sorbie, M McCoy, ...
Journal of Medical Ethics, 2020
Prevalence of Third-Party Tracking on COVID-19–Related Web Pages
MS McCoy, T Libert, D Buckler, DT Grande, AB Friedman
JAMA, 2020
Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform
T Torgerson, C Wayant, L Cosgrove, EA Akl, J Checketts, R Dal Re, J Gill, ...
BMJ evidence-based medicine 27 (1), 46-54, 2022
What does it mean to engage the public in the response to covid-19?
N Scheinerman, M McCoy
bmj 373, 2021
A content analysis of patient advocacy organization policies addressing institutional conflicts of interest
JH Brems, MS McCoy
AJOB Empirical Bioethics 10 (4), 215-221, 2019
On the ethics of vaccine nationalism: the case for the fair priority for residents framework
EJ Emanuel, A Buchanan, SY Chan, C Fabre, D Halliday, RJ Leland, ...
Ethics & international affairs 35 (4), 543-562, 2021
Dialysis-facility joint-venture ownership—hidden conflicts of interest
JS Berns, A Glickman, MS McCoy
New England Journal of Medicine 379 (14), 1295-1297, 2018
Health policy: Addressing conflicts of interest of public speakers at advisory committee meetings
MS McCoy, EJ Emanuel
Nature Reviews Clinical Oncology 13 (5), 267-268, 2016
The system can't perform the operation now. Try again later.
Articles 1–20